Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure
in patients with open-angle glaucoma or ocular hypertension. Contents. [hide].
Easy to read patient leaflet for brinzolamide drops. Includes indications, proper
use, special instructions, precautions, and possible side effects.
AZOPT (brinzolamide ophthalmic suspension) 1% contains a carbonic
anhydrase inhibitor formulated for multidose topical ophthalmic use.
Brinzolamide is ...
Learn about clinical pharmacology for the drug Azopt (Brinzolamide Ophthalmic
Brinzolamide eye drops are used in the treatment of glaucoma. Learn more about
brinzolamide, its side effects and applications at Patient.
SIMBRINZA<sup>®</sup> (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2
% combines two proven medications into a single treatment. The first ...
Jun 13, 2005 ... Description, Brinzolamide is a highly specific, non-competitive, reversible
carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme ...
Brinzolamide is a sulfonamide and carbonic anhydrase inhibitor with specific
affinity for carbonic anhydrase II. Following topical ocular administration, ...
Mar 28, 2016 ... The recommended dose is one drop of AZOPT® (brinzolamide ophthalmic
suspension) 1% in the affected eye(s) three times daily. AZOPT® ...
Find patient medical information for brinzolamide ophthalmic on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and